Taxpayer-Funded Bailout for Moderna Incoming!

Before the COVID-19 Plandemic, Moderna couldn’t get a product to market.

The pharmaceutical company never developed a drug or distributed a product.

Moderna was a failure!

And they’re a still a failure.

However, Moderna got bailed out by COVID-19.

The company received a government contract to develop a dangerous mRNA gene therapy utilizing American taxpayer dollars.

Moderna made billions off the sales of that product.

Now, Moderna faces a patent infringement lawsuit from two biotech companies claiming the COVID-19 jab manufacturer illegally used their technology to develop the shot.

Moderna attempted to have the lawsuit dismissed, arguing that the case should be directed at the U.S. government.

From Fierce Pharma:

Moderna’s motion to dismiss a patent infringement lawsuit centered on COVID-19 vaccine technology fell short after the company argued that the case should be directed at the U.S. government rather than itself.

After Arbutus Biopharma and Roivant’s Genevant Sciences sued Moderna in February for alleged patent infringement, the company countered with a motion to dismiss in May. In its motion, the company argued that the government—rather than itself—should defend against the claims because the company was simply providing doses under a federal contract.

But U.S. District Judge Mitchell Goldberg didn’t buy the argument. Dismissing the motion, he found (PDF) that the company failed to prove the government should face the lawsuit.

U.S. District Judge Mitchell Goldberg ruled for the second time in March that Moderna failed to prove the government was the proper target of the lawsuit.

As Reuters explained, Arbutus and Genevant seek royalties from Moderna’s COVID-19 shot.

U.S. District Judge Mitchell Goldberg ruled for the second time that Moderna had not yet shown that the government was the proper target of a lawsuit by Arbutus Biopharma Corp (ABUS.O) and Genevant Sciences GmbH.

A spokesperson for Genevant declined to comment on the decision. Representatives for Moderna, the U.S. Food and Drug Administration and the U.S. Department of Health and Human Services did not immediately respond to requests for comment Friday.

Warminster Township, Pennsylvania-based Arbutus and Genevant — a joint venture between Arbutus and Roivant Sciences Ltd (ROIV.O) — sued Cambridge, Massachusetts-based Moderna for patent infringement last year, seeking royalties from Moderna’s multi-billion-dollar COVID vaccines.

If Moderna is found guilty of patent infringement, they’ll have to pay royalties on billions of dollars of COVID-19 jab sales.

Now, the Biden administration has quietly stepped into the lawsuit to protect Moderna.

“Thanks to the U.S. Attorney in Delaware David Weiss, that’s also the guy who’s supposed to be investigating Hunter Biden but doesn’t seem to be, Moderna may not have to pay anything,” Tucker Carlson explained.

“That’s because Weiss is trying to put taxpayers, you, on the hook for Moderna’s alleged patent infringement.”

The scam goes like this:

• Moderna gets taxpayer dollars to develop its dangerous, ineffective product
• It’s owner becomes a billionaire due to massive profits
• Taxpayer dollars will bailout the company if it’s found guilty of stealing patented technology

“Wow is that a scam!” Carlson exclaimed.

WATCH:

The Biden administration is trying to bailout Moderna with your taxpayer dollars. pic.twitter.com/m576pj9LWl

— Tucker Carlson (@TuckerCarlson) March 23, 2023

FOX News reported:

The Biden administration quietly inserted itself into a private patent infringement lawsuit two biotech companies filed against COVID-19 vaccine maker Moderna, in a move experts said could establish a dangerous precedent.

In a surprise filing last month, U.S. Attorney David Weiss issued a “statement of interest” in the case on behalf of the Department of Defense and Department of Health and Human Services (HHS), invoking a rarely-used early 1900s law to argue that the federal government should take on any liability for patent infringement Moderna may be guilty of related to the development of its COVID-19 vaccine.

“Where, as here, the Government directly contracts to procure the allegedly infringing goods or services in a contract that grants authorization and consent, the ‘benefit to the Government’ is inherent,” the filing stated. “Indeed, the contractor’s compliance with the contract’s obligations alone demonstrate the benefit: that the Government obtains goods and services for which it pays.”

NATIONAL POLL: Do You Still Support President Trump?

The filing concluded that companies whose patents Moderna may have infringed during COVID-19 vaccine development should be limited to pursuing a claim against the federal government in the U.S. Court of Federal Claims.

Moderna – which received about $10 billion in taxpayer money to produce its COVID-19 vaccine and has since earned billions more in profits selling it – was sued in early 2022 by Genevant Sciences and Arbutus Biopharma Corp., which accused Moderna of using technology they have patented in its vaccine. The two companies have asked a federal court in Delaware to award them damages for the infringement.

Weiss then stepped in to support Moderna a year after it argued in court in a May 2022 filing that any damages should be paid by the federal government since it contracted the vaccine from the company amid a global health emergency. One week after Weiss’ filing, Moderna disclosed that it paid the federal government $400 million in a “catch-up payment.”

Rand Paul confronted Moderna CEO Stéphane Bancel about the $400 million in royalties paid to the NIH during a Senate hearing this week.

Moderna Announces COVID-19 Jab Patent License Agreement With U.S. Government